Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000183

Pres. Diagnostics & Genom sold 811 shares at $433.00 ($351,163)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2021-06-09 Sale −811 $433.00 $351,163 0 D: show line 1 in the form
Open-market sales · 811 sh · avg $433.00 · $351,163
Loading xslF345X03/edgar.xml…